Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Quality Assessment in Supportive Care in Head and Neck Cancer.

Bonomo P, Paderno A, Mattavelli D, Zenda S, Cavalieri S, Bossi P.

Front Oncol. 2019 Sep 18;9:926. doi: 10.3389/fonc.2019.00926. eCollection 2019. Review.

PMID:
31620372
2.

Locally advanced epithelial sinonasal tumors: The impact of multimodal approach.

Orlandi E, Cavalieri S, Granata R, Nicolai P, Castelnuovo P, Piazza C, Schreiber A, Turri-Zanoni M, Quattrone P, Miceli R, Infante G, Sessa F, Facco C, Calareso G, Iacovelli NA, Mattavelli D, Paderno A, Resteghini C, Locati LD, Licitra L, Bossi P.

Laryngoscope. 2019 Aug 1. doi: 10.1002/lary.28202. [Epub ahead of print]

PMID:
31369156
3.

Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell Carcinoma.

Locati LD, Serafini MS, Iannò MF, Carenzo A, Orlandi E, Resteghin C, Cavalieri S, Bossi P, Canevari S, Licitra L, De Cecco L.

Cancers (Basel). 2019 Jul 26;11(8). pii: E1057. doi: 10.3390/cancers11081057.

4.

Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract.

Locati LD, Cavalieri S, Bergamini C, Resteghini C, Alfieri S, Calareso G, Bossi P, Perrone F, Tamborini E, Quattrone P, Granata R, Galbiati D, Platini F, Orlandi E, Mariani L, Licitra L.

Head Neck. 2019 Oct;41(10):3670-3676. doi: 10.1002/hed.25891. Epub 2019 Jul 29.

PMID:
31355973
5.

Effect of antimicrobial stewardship with rapid MALDI-TOF identification and Vitek 2 antimicrobial susceptibility testing on hospitalization outcome.

Cavalieri SJ, Kwon S, Vivekanandan R, Ased S, Carroll C, Anthone J, Schmidt D, Baysden M, Destache CJ.

Diagn Microbiol Infect Dis. 2019 Oct;95(2):208-211. doi: 10.1016/j.diagmicrobio.2019.05.020. Epub 2019 Jun 6.

PMID:
31279585
6.

Clinical Utility of Advanced Microbiology Testing Tools.

Miller MB, Atrzadeh F, Burnham CA, Cavalieri S, Dunn J, Jones S, Mathews C, McNult P, Meduri J, Newhouse C, Newton D, Oberholzer M, Osiecki J, Pedersen D, Sweeney N, Whitfield N, Campos J; ASM Clinical and Public Health Microbiology Committee and the ASM Corporate Council.

J Clin Microbiol. 2019 Aug 26;57(9). pii: e00495-19. doi: 10.1128/JCM.00495-19. Print 2019 Sep. Review.

7.

PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents.

Cavalieri S, Perrone F, Milione M, Bianco A, Alfieri S, Locati LD, Bergamini C, Resteghini C, Galbiati D, Platini F, Licitra L, Bossi P.

Oncology. 2019;97(2):112-118. doi: 10.1159/000500246. Epub 2019 May 21.

PMID:
31112973
8.

Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting.

Depenni R, Cossu Rocca M, Ferrari D, Azzarello G, Baldessari C, Alù M, Nolé F, Codecà C, Boscolo G, Piccininni M, Cavalieri S, Bossi P.

Eur J Cancer. 2019 Jul;115:4-12. doi: 10.1016/j.ejca.2019.03.022. Epub 2019 May 10.

PMID:
31082692
9.

Identification of potentially druggable molecular alterations in skin adnexal malignancies.

Cavalieri S, Busico A, Capone I, Conca E, Dallera E, Quattrone P, Licitra L, Pruneri G, Bossi P, Perrone F.

J Dermatol. 2019 Jun;46(6):507-514. doi: 10.1111/1346-8138.14889. Epub 2019 Apr 30.

PMID:
31038235
10.

Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?

Cavalieri S, Platini F, Bergamini C, Resteghini C, Galbiati D, Bossi P, Perrone F, Tamborini E, Quattrone P, Licitra L, Locati LD, Alfieri S.

Expert Opin Investig Drugs. 2019 May;28(5):435-443. doi: 10.1080/13543784.2019.1598376. Epub 2019 Apr 4. Review.

PMID:
30897975
11.

Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis.

Galli G, Cavalieri S, Di Guardo L, Cimminiello C, Nichetti F, Corti F, Garcia MA, Pappalardi B, Fallai C, de Braud F, Platania M, Del Vecchio M.

Oncol Res Treat. 2019;42(4):186-194. doi: 10.1159/000497211. Epub 2019 Mar 5.

12.

Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study.

Mariani G, Galli G, Cavalieri S, Valagussa P, Bianchi GV, Capri G, Cresta S, Ferrari L, Damian S, Duca M, de Braud F, Moliterni A.

Breast J. 2019 Mar;25(2):237-242. doi: 10.1111/tbj.13197. Epub 2019 Feb 27.

13.

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma.

van Boxtel W, Locati LD, van Engen-van Grunsven ACH, Bergamini C, Jonker MA, Fiets E, Cavalieri S, Tooten S, Bos E, Quattrone P, Verhaegh GW, Schalken JA, Licitra L, van Herpen CML; PALGA Group.

Eur J Cancer. 2019 Mar;110:62-70. doi: 10.1016/j.ejca.2018.12.035. Epub 2019 Feb 13.

PMID:
30771738
14.

Random laser based method for direct measurement of scattering properties.

Tommasi F, Ignesti E, Fini L, Martelli F, Cavalieri S.

Opt Express. 2018 Oct 15;26(21):27615-27627. doi: 10.1364/OE.26.027615.

PMID:
30469824
15.

Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.

Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolò V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F.

Neurobiol Dis. 2019 Apr;124:14-28. doi: 10.1016/j.nbd.2018.10.018. Epub 2018 Oct 30.

PMID:
30389403
16.

Prevalence and phenotype of the c.1529C>T SPG7 variant in adult-onset cerebellar ataxia in Italy.

Mancini C, Giorgio E, Rubegni A, Pradotto L, Bagnoli S, Rubino E, Prontera P, Cavalieri S, Di Gregorio E, Ferrero M, Pozzi E, Riberi E, Ferrero P, Nigro P, Mauro A, Zibetti M, Tessa A, Barghigiani M, Antenora A, Sirchia F, Piacentini S, Silvestri G, De Michele G, Filla A, Orsi L, Santorelli FM, Brusco A.

Eur J Neurol. 2019 Jan;26(1):80-86. doi: 10.1111/ene.13768. Epub 2018 Sep 3.

PMID:
30098094
17.

Fatigue, a major still underestimated issue.

Ripamonti CI, Antonuzzo A, Bossi P, Cavalieri S, Roila F, Fatigoni S.

Curr Opin Oncol. 2018 Jul;30(4):219-225. doi: 10.1097/CCO.0000000000000451. Review.

PMID:
29877886
18.

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.

Cavalieri S, Perrone F, Miceli R, Ascierto PA, Locati LD, Bergamini C, Granata R, Alfieri S, Resteghini C, Galbiati D, Busico A, Paielli N, Patuzzo R, Maurichi A, Gallino G, Ruggeri R, Mariani L, Palla M, Licitra L, Bossi P.

Eur J Cancer. 2018 Jul;97:7-15. doi: 10.1016/j.ejca.2018.04.004. Epub 2018 May 4.

PMID:
29734047
19.

Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers.

Resteghini C, Perrone F, Miceli R, Bergamini C, Alfieri S, Orlandi E, Guzzo M, Granata R, Galbiati D, Cavalieri S, Locati L, Licitra L, Bossi P.

Tumori. 2018 Jun;104(3):213-220. doi: 10.1177/0300891618765558. Epub 2018 Apr 18.

PMID:
29714670
20.

Lenvatinib-induced renal failure: two first-time case reports and review of literature.

Cavalieri S, Cosmai L, Genderini A, Nebuloni M, Tosoni A, Favales F, Pistillo P, Bergamini C, Bossi P, Licitra L, Locati LD, Alfieri S.

Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):379-385. doi: 10.1080/17425255.2018.1461839. Epub 2018 Apr 13. Review.

21.

Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.

Cavalieri S, Rivoltini L, Bergamini C, Locati LD, Licitra L, Bossi P.

Cancer Treat Rev. 2018 Apr;65:78-86. doi: 10.1016/j.ctrv.2018.03.003. Epub 2018 Mar 20. Review.

PMID:
29574334
22.

Current status and perspectives in immunotherapy for metastatic melanoma.

Marconcini R, Spagnolo F, Stucci LS, Ribero S, Marra E, Rosa F, Picasso V, Di Guardo L, Cimminiello C, Cavalieri S, Orgiano L, Tanda E, Spano L, Falcone A, Queirolo P; Italian Melanoma Intergroup (IMI).

Oncotarget. 2018 Jan 3;9(15):12452-12470. doi: 10.18632/oncotarget.23746. eCollection 2018 Feb 23. Review.

23.

Spinocerebellar Ataxia Tethering PCR: A Rapid Genetic Test for the Diagnosis of Spinocerebellar Ataxia Types 1, 2, 3, 6, and 7 by PCR and Capillary Electrophoresis.

Cagnoli C, Brussino A, Mancini C, Ferrone M, Orsi L, Salmin P, Pappi P, Giorgio E, Pozzi E, Cavalieri S, Di Gregorio E, Ferrero M, Filla A, De Michele G, Gellera C, Mariotti C, Nethisinghe S, Giunti P, Stevanin G, Brusco A.

J Mol Diagn. 2018 May;20(3):289-297. doi: 10.1016/j.jmoldx.2017.12.006. Epub 2018 Feb 17.

PMID:
29462666
24.

Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer.

Galli G, Bregni G, Cavalieri S, Porcu L, Baili P, Hade A, Di Salvo F, Sant M, Agresti R, Gennaro M, Folli S, De Santis MC, Paolini B, Carcangiu ML, de Braud F, Di Cosimo S.

Breast Care (Basel). 2017 Dec;12(6):391-394. doi: 10.1159/000479582. Epub 2017 Dec 12.

25.

Immunotherapy for recurrent/metastatic head and neck cancer.

Alfieri S, Cavalieri S, Licitra L.

Curr Opin Otolaryngol Head Neck Surg. 2018 Apr;26(2):152-156. doi: 10.1097/MOO.0000000000000448. Review.

PMID:
29432222
26.

Verification of Diagnosis in Tuberculosis: A Case Report and Discussion.

Dave AM, Adelrahman A, Mehta V, Cavalieri S, Vivekanadan R.

Cureus. 2017 Sep 3;9(9):e1650. doi: 10.7759/cureus.1650.

27.

Precursor propagation in inhomogeneous broadened media: experimental and numerical simulation.

Tommasi F, Ignesti E, Fini L, Cavalieri S.

Opt Lett. 2017 Nov 1;42(21):4498-4501. doi: 10.1364/OL.42.004498.

PMID:
29088197
28.

Uncommon somatic mutations in metastatic NUT midline carcinoma.

Cavalieri S, Stathis A, Fabbri A, Sonzogni A, Perrone F, Tamborini E, Pelosi G, de Braud F, Platania M.

Tumori. 2017 Nov 15;103(Suppl. 1):e5-e8. doi: 10.5301/tj.5000685.

PMID:
28967088
29.

Clinical implications for pro-GRP in small cell lung cancer. A single center experience.

Cavalieri S, Morelli D, Martinetti A, Galli G, Nichetti F, de Braud F, Platania M.

Int J Biol Markers. 2018 Jan;33(1):55-61. doi: 10.5301/ijbm.5000305.

30.

Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients.

Resteghini C, Cavalieri S, Galbiati D, Granata R, Alfieri S, Bergamini C, Bossi P, Licitra L, Locati LD.

Best Pract Res Clin Endocrinol Metab. 2017 Jun;31(3):349-361. doi: 10.1016/j.beem.2017.04.012. Epub 2017 May 10. Review.

PMID:
28911730
31.

Unusual Skin Carcinomas Induced by BRAF Inhibitor for Metastatic Melanoma: A Case Report.

Cavalieri S, Di Guardo L, Cossa M, Cimminiello C, Del Vecchio M.

J Clin Diagn Res. 2017 Jul;11(7):XD06-XD08. doi: 10.7860/JCDR/2017/26881.10200. Epub 2017 Jul 1.

32.

Depth sensitivity of frequency domain optical measurements in diffusive media.

Binzoni T, Sassaroli A, Torricelli A, Spinelli L, Farina A, Durduran T, Cavalieri S, Pifferi A, Martelli F.

Biomed Opt Express. 2017 May 17;8(6):2990-3004. doi: 10.1364/BOE.8.002990. eCollection 2017 Jun 1.

33.

A novel homozygous change of CLCN2 (p.His590Pro) is associated with a subclinical form of leukoencephalopathy with ataxia (LKPAT).

Giorgio E, Vaula G, Benna P, Lo Buono N, Eandi CM, Dino D, Mancini C, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Giordana MT, Depienne C, Brusco A.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):894-896. doi: 10.1136/jnnp-2016-315525. Epub 2017 May 4. No abstract available.

PMID:
28473625
34.

Ultimate Limit in the Spectral Resolution of Extreme Ultraviolet Frequency Combs.

Corsi C, Liontos I, Bellini M, Cavalieri S, Cancio Pastor P, Siciliani de Cumis M, Eramo R.

Phys Rev Lett. 2017 Apr 7;118(14):143201. doi: 10.1103/PhysRevLett.118.143201. Epub 2017 Apr 3.

PMID:
28430481
35.

The steroid response to human chorionic gonadotropin (hCG) stimulation in men with Klinefelter syndrome does not change using immunoassay or mass spectrometry.

Roli L, Santi D, Belli S, Tagliavini S, Cavalieri S, De Santis MC, Baraldi E, Fanelli F, Mezzullo M, Granata AR, Pagotto U, Pasquali R, Rochira V, Carani C, Simoni M, Trenti T.

J Endocrinol Invest. 2017 Aug;40(8):841-850. doi: 10.1007/s40618-017-0653-7. Epub 2017 Mar 21.

PMID:
28326509
36.

Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genes.

Di Gregorio E, Riberi E, Belligni EF, Biamino E, Spielmann M, Ala U, Calcia A, Bagnasco I, Carli D, Gai G, Giordano M, Guala A, Keller R, Mandrile G, Arduino C, Maffè A, Naretto VG, Sirchia F, Sorasio L, Ungari S, Zonta A, Zacchetti G, Talarico F, Pappi P, Cavalieri S, Giorgio E, Mancini C, Ferrero M, Brussino A, Savin E, Gandione M, Pelle A, Giachino DF, De Marchi M, Restagno G, Provero P, Cirillo Silengo M, Grosso E, Buxbaum JD, Pasini B, De Rubeis S, Brusco A, Ferrero GB.

Clin Genet. 2017 Oct;92(4):415-422. doi: 10.1111/cge.13009. Epub 2017 Jul 25.

PMID:
28295210
37.

Evaluation of Staphylococcus aureus Bacteremia: Academic and Community-Based Management Within the Same Health System.

Ased S, Rayes H, Dhami J, Amosson N, Fordjour A, Macaraeg J, Vivekanandan R, Wilson J, Cabri A, Davids M, Anthone J, Cavalieri S, Destache CJ.

Infect Control Hosp Epidemiol. 2017 Jun;38(6):740-742. doi: 10.1017/ice.2017.30. Epub 2017 Mar 15.

PMID:
28294090
38.

A case of Feingold type 2 syndrome associated with keratoconus refines keratoconus type 7 locus on chromosome 13q.

Sirchia F, Di Gregorio E, Restagno G, Grosso E, Pappi P, Talarico F, Savin E, Cavalieri S, Giorgio E, Mancini C, Pasini B, Mehta JS, Brusco A.

Eur J Med Genet. 2017 Apr;60(4):224-227. doi: 10.1016/j.ejmg.2017.01.010. Epub 2017 Jan 31.

39.

A methodological approach for using high-level Petri Nets to model the immune system response.

Pennisi M, Cavalieri S, Motta S, Pappalardo F.

BMC Bioinformatics. 2016 Dec 22;17(Suppl 19):498. doi: 10.1186/s12859-016-1361-6.

40.

Exome sequencing in children of women with skewed X-inactivation identifies atypical cases and complex phenotypes.

Giorgio E, Brussino A, Biamino E, Belligni EF, Bruselles A, Ciolfi A, Caputo V, Pizzi S, Calcia A, Di Gregorio E, Cavalieri S, Mancini C, Pozzi E, Ferrero M, Riberi E, Borelli I, Amoroso A, Ferrero GB, Tartaglia M, Brusco A.

Eur J Paediatr Neurol. 2017 May;21(3):475-484. doi: 10.1016/j.ejpn.2016.12.005. Epub 2016 Dec 19.

41.

Robustness of replica symmetry breaking phenomenology in random laser.

Tommasi F, Ignesti E, Lepri S, Cavalieri S.

Sci Rep. 2016 Nov 16;6:37113. doi: 10.1038/srep37113.

42.

A new class of optical sensors: a random laser based device.

Ignesti E, Tommasi F, Fini L, Martelli F, Azzali N, Cavalieri S.

Sci Rep. 2016 Oct 11;6:35225. doi: 10.1038/srep35225.

43.

Time-domain Raman analytical forward solvers.

Martelli F, Binzoni T, Sekar SK, Farina A, Cavalieri S, Pifferi A.

Opt Express. 2016 Sep 5;24(18):20382-99. doi: 10.1364/OE.24.020382.

PMID:
27607645
44.

Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia.

Costantini A, Laureti T, Pala MI, Colangeli M, Cavalieri S, Pozzi E, Brusco A, Salvarani S, Serrati C, Fancellu R.

J Neurol. 2016 Nov;263(11):2170-2178. Epub 2016 Aug 3.

45.

Combined therapy with dabrafenib and trametinib in BRAF-mutated metastatic melanoma in a real-life setting: the INT Milan experience.

Cavalieri S, Di Guardo L, Cimminiello C, Bono A, Tolomio E, Colombetti A, Valeri B, Di Tolla G, de Braud F, Del Vecchio M.

Tumori. 2016 Oct 13;102(5):501-507. doi: 10.5301/tj.5000539. Epub 2016 Jul 27.

PMID:
27470608
46.

Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.

Giorgio E, Ciolfi A, Biamino E, Caputo V, Di Gregorio E, Belligni EF, Calcia A, Gaidolfi E, Bruselles A, Mancini C, Cavalieri S, Molinatto C, Cirillo Silengo M, Ferrero GB, Tartaglia M, Brusco A.

Am J Med Genet A. 2016 Jul;170(7):1772-9. doi: 10.1002/ajmg.a.37649. Epub 2016 Apr 25.

47.

Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer.

Pappalardo F, Russo G, Candido S, Pennisi M, Cavalieri S, Motta S, McCubrey JA, Nicoletti F, Libra M.

PLoS One. 2016 Mar 25;11(3):e0152104. doi: 10.1371/journal.pone.0152104. eCollection 2016.

48.

Array-Comparative Genomic Hybridization Analysis in Fetuses with Major Congenital Malformations Reveals that 24% of Cases Have Pathogenic Deletions/Duplications.

Di Gregorio E, Gai G, Botta G, Calcia A, Pappi P, Talarico F, Savin E, Ribotta M, Zonta A, Mancini C, Giorgio E, Cavalieri S, Restagno G, Ferrero GB, Viora E, Pasini B, Grosso E, Brusco A, Brussino A.

Cytogenet Genome Res. 2015;147(1):10-6. doi: 10.1159/000442308. Epub 2015 Dec 12.

49.

A novel 3q29 deletion associated with autism, intellectual disability, psychiatric disorders, and obesity.

Biamino E, Di Gregorio E, Belligni EF, Keller R, Riberi E, Gandione M, Calcia A, Mancini C, Giorgio E, Cavalieri S, Pappi P, Talarico F, Fea AM, De Rubeis S, Cirillo Silengo M, Ferrero GB, Brusco A.

Am J Med Genet B Neuropsychiatr Genet. 2016 Mar;171B(2):290-9. doi: 10.1002/ajmg.b.32406. Epub 2015 Dec 1.

50.

Optimal estimation reconstruction of the optical properties of a two-layered tissue phantom from time-resolved single-distance measurements.

Martelli F, Del Bianco S, Spinelli L, Cavalieri S, Di Ninni P, Binzoni T, Jelzow A, Macdonald R, Wabnitz H.

J Biomed Opt. 2015 Nov;20(11):115001. doi: 10.1117/1.JBO.20.11.115001.

Supplemental Content

Loading ...
Support Center